Login
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
.......... Issued in the interest of Investors"
OTP Verification
Regenerate OTP
Alert Message
Please contact to emkayassist@emkayglobal.com
Select Mobile Number and Email for OTP
Please select Mobile No and Email Id for OTP
Generate password
Customer Guest
Login | Register
Forgot Customer Code
Login | Register|Forgot password?
Would you like to create a personalised login id for logging in to Emkay Website ?
Change Personalised Login ID
Avience Biomedicals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018: Reconciliation o...more...
Avience Biomedicals Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q 30 June 2026 FY 2026-27more...
Avience Biomedicals Limited has informed the Exchange about Certificate in terms of Regulation 74(5) under SEBI (Depositories and Participants) Regul...more...
Avience Biomedicals Limited has informed the Exchange about Transcriptmore...
Avience Biomedicals Limited has informed the Exchange regarding AVIENCE Update: Avience Biomedicals Limited has submitted to the Exchange the financi...more...
Avience Biomedicals Limited has informed the Exchange about Link of Recording of con. call held as on 24.07.2026more...
Avience Biomedicals Limited has informed the Exchange about Investor Presentationmore...
Avience Biomedicals Limited has informed the Exchange about Schedule of meet on earning conference call for investors Schedule on July 24 20...more...
As of June 2026 64.59% is owned by Indian Promoters and 35.41% by Public. Institutional holds 12.14% (Insurance Companies 1.17%) and Non-Institutiona...more...
Avience Biomedicals Limited has submitted to the Exchange the financial results for the period ended March 31 2026.more...
Avience Biomedicals Ltd. makes a strong debut on the bourses with scrip got listed at Rs 395.20 on the Bombay Stock Exchange a 90.00 per cent premium...more...
Avience Biomedicals Ltd. has announced public offering of 1453800 shares at a price of Rs 10.00 each for Cash at a Premium of Rs 198.00 per ...more...
BOARD MEETINGS Company Name : Par Drugs & Chem. Date : 22-08-2026
Latest Videos